openPR Logo
Press release

Patient-Derived Xenograft/PDX Model Market Share, Trends, Analysis and Forecast 2023-2029

01-25-2023 06:24 PM CET | Health & Medicine

Press release from: Orion Market Research

Patient-Derived Xenograft/PDX Model Market Share, Trends,

The global gastroretentive drug delivery systems market is anticipated to grow at a CAGR of around 6.3% during the forecast period. The rising prevalence of functional gastrointestinal disorders (FGIDs), and gastric disorders majorly among the geriatric population globally is the major factor augmenting the growth of the gastroretentive drug delivery systems. The aged population is more susceptible to long-standing conditions such as dyspepsia, irritable bowel syndrome, inflammatory bowel disease (Crohn's disease and ulcerative colitis), celiac disease, and GERD due to the weak immune system and aging factor. Whereas the increasing prevalence of gastric cancer is also the factor due to which the adoption of advanced drug delivery systems is gaining popularity. Among major economies, the US is the region with a large presence of people affected with gastric cancer, and this burden is increasing at an alarming rate.
According to the American Cancer Society's estimates, in 2021, in the US, there were 26,560 new cases of stomach cancer were found, among which 16,160 were in men, and 10,400 were in women. Due to increased cases of gastric cancer, and other gastric disorders, the key players are focusing on investing high expenditure on the development of new and advanced drug delivery systems.

To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/patient-derived-xenograft-pdx-model-market

Moreover, the rapid development in healthcare infrastructure, an increasing number of hospitals and online pharmacies across the regions, and development in drug delivery systems are also the prominent factors contributing to driving the market growth.

Market Coverage

• The market number available for - 2020-2027
• Base year- 2020
• Forecast period- 2021-2027
• Segment Covered-
o By Type
o By Dosage Forms
o By Distribution Channel
• Regions Covered-
o North America
o Europe
o Asia-Pacific
o Rest of the World
• Competitive Landscape- F. Hoffmann-La Roche AG, Sun Pharmaceutical Industries Ltd., GlaxoSmithKline PLC, Assertio Holdings, Inc., Alcon Vision LLC, Lupin, Pfizer Inc., and others.

Key questions addressed by the report

• What is the market growth rate?
• Which segment and region dominate the market in the base year?
• Which segment and region will project the fastest growth in the market?
• How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
• Who is the leader in the market?
• How are players addressing challenges to sustain growth?
• Where is the investment opportunity?

Global Gastroretentive Drug Delivery Systems Market Report Segment

By Type

• High-Density Systems
• Expandable Drug Delivery Systems
• Bioadhesive Drug Delivery Systems
• Floating Drug Delivery Systems
• Others

By Dosage form

• Capsule
• Microspheres
• Tablets
• Liquid
• Others

By Distribution Channel

• Retail Pharmacies
• Hospital Pharmacies
• Online Pharmacies

A full report of Patient-Derived Xenograft/PDX Model Market is available at: https://www.omrglobal.com/industry-reports/patient-derived-xenograft-pdx-model-market

Patient-Derived Xenograft/PDX Model Market- Segment by Region

North America

• United States
• Canada

Europe

• Germany
• United Kingdom
• France
• Spain
• Italy
• Rest of Europe

Asia-Pacific

• China
• Japan
• India
• Rest of Asia-Pacific

Rest of the World

• Middle East & Africa
• Latin America

Company Profiles

• Abnova Corp.
• Aragen Life Sciences Pvt. Ltd.
• Biocytogen
• Champions Oncology, Inc.
• Charles River Laboratories International, Inc.
• Crown Bioscience Inc.,
• Envigo RMS LLC
• EPO Berlin-Buch GmbH
• ExploraBioLabs
• Genesis Biotechnology Group
• Hera Biolabs
• Horizon Discovery Ltd.
• JSR Corp.

Reasons to Buying From us -

1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.

Visit More Report at

https://www.asiatimeskorea.com/press-release/acidophilus-probiotic-%ec%8b%9c%ec%9e%a5-%eb%8f%99%ed%96%a5-%ec%97%b0%ea%b5%ac-%eb%b3%b4%ea%b3%a0%ec%84%9c-%ec%84%b1%ec%9e%a5-%ea%b8%b0%ed%9a%8c-%ec%98%88%ec%b8%a1-2022-2028/192200/

https://www.diario-ya.com/regionales/%e5%a4%84%e6%96%b9%e7%9a%ae%e8%82%a4%e7%97%85%e8%8d%af%e7%89%a9%e5%b8%82%e5%9c%ba%e8%b6%8b%e5%8a%bf%e3%80%81%e6%9c%aa%e6%9d%a5%e5%b1%95%e6%9c%9b%e3%80%81%e5%88%86%e6%9e%90%e5%92%8c%e9%a2%84%e6%b5%8b-2/271177/

https://sportmsr.com/%d8%b7%d8%a8-%d8%a7%d9%84%d8%a3%d9%84%d9%85-%d9%87%d8%b4%d8%a7%d8%b4%d8%a9-%d8%a7%d9%84%d8%b9%d8%b8%d8%a7%d9%85-%d8%ad%d8%ac%d9%85-%d8%a7%d9%84%d8%b3%d9%88%d9%82-%d8%8c-%d8%ad%d8%b5%d8%a9-%d8%8c/

https://revistaeconomiasocial.com/2022/12/21/hiperlipidemia-medicamentos-recetados-tendencias-del-mercado-informe-de-investigacion-crecimiento-oportunidades-pronostico-2022-2028/

https://citytoday-hildesheim.de/index.php/2022/12/21/gaucher-krankheitsmedikamente-marktbericht-2022-nach-hauptakteuren-trends-grose-anteil-und-prognose-2022-2028/

Media Contact:

Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Patient-Derived Xenograft/PDX Model Market Share, Trends, Analysis and Forecast 2023-2029 here

News-ID: 2900238 • Views:

More Releases from Orion Market Research

Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, Leading Players and Growth Opportunities by 2033
Infrastructure as Code (IaC) Service Market Size Analysis, Competitive Insights, …
Infrastructure as Code (IaC) Service Market was valued at approximately USD 0.932 billion, and it's projected to expand to around USD 7.509 billion by 2033, achieving a robust CAGR of 23.2% from 2024 to 2033. Infrastructure as Code (IaC) Service Market Overview The Infrastructure as Code (IaC) Service Market is experiencing remarkable expansion, fueled by the escalating need for scalable, automated infrastructure deployment across cloud and enterprise environments. In 2023, the market
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to Understanding the Process
Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market : A Guide to …
Ultra High‐Performance Liquid Chromatography (UHPLC) Columns Market is estimated to be valued at USD 2.5 billion, and is projected to grow to approximately USD 4.8 billion by 2033, representing a compound annual growth rate (CAGR) of about 7.8% from 2024 to 2033. Ultra High-Performance Liquid Chromatography (UHPLC) Columns Market Overview The UHPLC columns market is on a strong growth trajectory, fueled by increasing demand for rapid, high-resolution analytical techniques across pharmaceuticals, biotechnology,
Property Management Service Market Rising Demand and Growth Forecast Through 2033
Property Management Service Market Rising Demand and Growth Forecast Through 203 …
Property Management Service Market was valued at approximately USD 17.3 billion. It is anticipated to reach around USD 32.0 billion by 2033, growing at a compound annual growth rate (CAGR) of 7.3% from 2024 to 2033. Property Management Service Market Overview The Property Management Service Market is witnessing steady growth due to increasing urbanization, rising investments in real estate, and a growing demand for outsourced property management solutions. Property owners are increasingly
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSilicon Technologies Co., Ltd., ZTE Corporation,
5G Chipset Market Set to Witness Significant Growth by 2033 | Apple Inc., HiSili …
The global 5G chipset market was valued at USD 33.75 billion in 2024 and is projected to reach USD 502.66 billion by 2033, growing at a compound annual growth rate (CAGR) of 35% from 2025 to 2033. 5G Chipset Market Overview The 5G chipset market is experiencing rapid growth, driven by the global rollout of 5G networks and the increasing demand for high-speed, low-latency connectivity across various applications, including smartphones, IoT

All 5 Releases


More Releases for Xenograft/PDX

Advancements in Patient-Derived Xenograft (PDX) Models and Bioluminescence Imagi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Patient Derived Xenograft (PDX) Models Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The market for patient derived xenograft (PDX) models has seen a significant expansion in recent years. The market that was valued at $0.4 billion in 2024 is projected to reach $0.47 billion
Evolving Market Trends In The Patient Derived Xenograft (PDX) Models Industry: A …
The Patient Derived Xenograft (PDX) Models Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Patient Derived Xenograft (PDX) Models Market Size During the Forecast Period? The patient-derived xenograft (PDX) models market, valued at $0.4 billion in 2024, is expected to grow to
Patient-derived Xenograft (PDX) Models Market Outlook and Future Projections for …
The patient-derived xenograft (pdx) models market represents a dynamic and continually evolving landscape, shaped by changing consumer demands and technological advancements. In this comprehensive report, we provide an in-depth exploration of the market, designed for a wide range of stakeholders including manufacturers, suppliers, distributors, and investors. Our goal is to equip industry participants with essential insights that enable informed decision-making in an ever-changing market environment. This analysis not only examines
[Latest] Patient Derived Xenograft (Pdx) Models Market : An Overview
The ""Patient Derived Xenograft (Pdx) Models Market"" is expected to reach USD xx.x billion by 2031, indicating a compound annual growth rate (CAGR) of xx.x percent from 2024 to 2031. The market was valued at USD xx.x billion In 2023. Growing Demand and Growth Potential in the Global Patient Derived Xenograft (Pdx) Models Market, 2024-2031 Verified Market Research's most recent report, ""Patient Derived Xenograft (Pdx) Models Market: Global Industry Trends, Share,
Patient Derived Xenograft (PDX) Models Market Market Opportunities And Key Insig …
𝐆𝐫𝐨𝐰𝐭𝐡 𝐌𝐚𝐫𝐤𝐞𝐭 𝐑𝐞𝐩𝐨𝐫𝐭𝐬 published a detailed report on 𝐆𝐥𝐨𝐛𝐚𝐥 𝐏𝐚𝐭𝐢𝐞𝐧𝐭 𝐃𝐞𝐫𝐢𝐯𝐞𝐝 𝐗𝐞𝐧𝐨𝐠𝐫𝐚𝐟𝐭 (𝐏𝐃𝐗) 𝐌𝐨𝐝𝐞𝐥𝐬 𝐌𝐚𝐫𝐤𝐞𝐭 for the clients that want to explore new market avenues, get in-depth insights on the market products, maximize their revenue, and review the strategies implemented by prominent players in the market. The Global Patient Derived Xenograft (PDX) Models Market was valued at USD 113.5 Million in 2019 and is anticipated to reach 283.3 Million by 2027,
Patient-Derived Xenograft/PDX Model Market is Driven by Increasing use of PDX Mo …
A patient-derived xenograft (PDX) is a cancer model created by transplanting tumor tissue from a human patient into an immunodeficient animal. This allows researchers to study the tumor in a living system and to test potential treatments. PDX models have several advantages over other types of cancer models. They more accurately reflect the heterogeneity of human tumors, and they can be used to study the interactions between the tumor and the